MLICM
VIGL

Metropolitan Life Insurance Company (MetLife)’s Vigil Neuroscience VIGL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-944
Closed -$8.87K – 2449
2023
Q2 		$8.87K Buy
+944
New +$8.87K ﹤0.01% 2359